Regional scientific and medical conferences

We are actively participating in all regional scientific and medical conferences to make sure our technological achievements are well known and new research is always following latest scientific trends

is made up by many dedicated individuals that work together as a team to help facilitate the healthcare innovation process. We are passionate about cutting-edge healthcare technologies with a focus on those that will have the greatest societal impact and meaningfully improve patient care.

Clinical trials and related projects

To ensure quality and efficiency of medical products we are continuously performing clinical trials with various groups of patients, we are also collaborating with other laboratories working in the same area of research to share knowledge and experience.

  • A Phase I trial tests an experimental treatment on a small group of often healthy people (20 to 80) to judge its safety and side effects and to find the correct drug dosage.
  • A Phase II trial uses more people (100 to 300). While the emphasis in Phase I is on safety, the emphasis in Phase II is on effectiveness. This phase aims to obtain preliminary data on whether the drug works in people who have a certain disease or condition. These trials also continue to study safety, including short-term side effects. This phase can last several years.
  • A Phase III trial gathers more information about safety and effectiveness, studying different populations and different dosages, using the drug in combination with other drugs. The number of subjects usually ranges from several hundred to about 3,000 people. If the FDA agrees that the trial results are positive, it will approve the experimental drug or device.
  • A Phase IV trial for drugs or devices takes place after the FDA approves their use. A device or drug's effectiveness and safety are monitored in large, diverse populations. Sometimes, the side effects of a drug may not become clear until more people have taken it over a longer period of time.

Collaboration with universities

As part of our Academic Relations Programme researchers can collaborate with experts from multiple disciplines, such as dentistry, nursing, pharmacy, public health, and veterinary medicine. Such collaboration enables our doctors to turn discoveries into preventions, treatments, and cures for diseases such as cancer and diabetes more quickly and efficiently.

Industry partnerships give students and faculty additional funding. By striking up corporate partnerships, universities have more resources to undertake research, and they’re able to diversify their research areas.
But—it’s not all about the money. If you break up the university benefits into a pie chart, one big slice would be industry feedback and guidance. Universities know that some problems can’t be solved in isolation in a lab, and industry feedback is key to taking an invention or product from conception to market.